Publication | Open Access

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia

Systems PharmacologyHematological MalignancyMedicineMalignant Blood DisorderMixed-phenotype Acute LeukemiaImmunologyBcl2 SignalingTherapeutic SensitivityAdult T-cell Leukemia-lymphomaSystems BiologyImmunotherapyCell BiologyCell SignalingTumor Microenvironment